-
Study aim
-
Determining the therapeutic effect of recurrent transcranial magnetic stimulation of the brain with a frequency of 1 Hz and LDLPFC target in patients with obsessive-compulsive disorder without response to drug therapy
-
Design
-
Clinical trial with control group, double-blind, randomized phase 2-3 on 32 patients. Random number table was used for randomization.
-
Settings and conduct
-
A double-blind clinical trial on patients with obsessive-compulsive disorder without response to treatment among outpatients admitted to Shahid Beheshti Hospital. Blindness is based on a random number table, and the therapist and patient are unaware of those who are blind. The study is performed in two groups and 16 patients in each group. The first group will receive effective nausea and the second group ineffective mobility, and the Yale Brown, Hamilton Anxiety, and Depression Questionnaires will be completed three times, the day before hospitalization, the day after treatment, and three months later during the interview.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: People over 18 years of age and right-handed with a diagnosis of moderate to high OCD on the YBOCS scale who have not responded to at least two first-line drugs despite a sufficient dose and 12-week course of treatment Exclusion criteria: Comorbidity with other psychiatric disorders except major depressive disorder, seizures, pregnancy, unstable medical conditions, cerebral metal implants, pacemaker, inner ear prosthesis
-
Intervention groups
-
The first group will receive 1 Hz stimulation on the lateral dorsal lateral cortex (L-DLPFC) and the second group will receive ineffective stimulation on the same area. They will receive 20 sessions twice a week and 3 times a week.
-
Main outcome variables
-
Symptoms of obsessive-compulsive disorder